ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Shorter treatment in chronic Chagas disease.[Editorial]: a new promise? (2024)
Bestetti, Reinaldo B; Bocchi, Edimar Alcides
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: DOENÇA CRÔNICA, TERAPIAS COMPLEMENTARES, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BESTETTI, Reinaldo B e BOCCHI, Edimar Alcides. Shorter treatment in chronic Chagas disease.[Editorial]: a new promise?. Lancet infectious diseases. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76872. Acesso em: 02 nov. 2025. , 2024
APA
Bestetti, R. B., & Bocchi, E. A. (2024). Shorter treatment in chronic Chagas disease.[Editorial]: a new promise? Lancet infectious diseases. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S1473-3099(23)00687-4
NLM
Bestetti RB, Bocchi EA. Shorter treatment in chronic Chagas disease.[Editorial]: a new promise? [Internet]. Lancet infectious diseases. 2024 ; 24( 4): 333-334.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76872
Vancouver
Bestetti RB, Bocchi EA. Shorter treatment in chronic Chagas disease.[Editorial]: a new promise? [Internet]. Lancet infectious diseases. 2024 ; 24( 4): 333-334.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76872
Artigo de periodico
Obituary Euphrosyne Setsu Umezawa (2024)
Andrade junior, Heitor Franco de
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE JUNIOR, Heitor Franco de. Obituary Euphrosyne Setsu Umezawa. Lancet infectious diseases, v. 24, n. 1, p. 20-20, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/59028. Acesso em: 02 nov. 2025.
APA
Andrade junior, H. F. de. (2024). Obituary Euphrosyne Setsu Umezawa. Lancet infectious diseases, 24( 1), 20-20. doi:10.1016/S1473-3099(23)00775-2
NLM
Andrade junior HF de. Obituary Euphrosyne Setsu Umezawa [Internet]. Lancet infectious diseases. 2024 ; 24( 1): 20-20.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59028
Vancouver
Andrade junior HF de. Obituary Euphrosyne Setsu Umezawa [Internet]. Lancet infectious diseases. 2024 ; 24( 1): 20-20.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59028
Artigo de periodico
Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010-15: a population-based, longitudinal study (2020)
Ranzani, Otavio T; Rodrigues, Laura C; Bombarda, Sidney; Minto, Catia M; Waldman, Eliseu Alves ; Carvalho, Carlos Roberto de
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: TUBERCULOSE, SOBREVIDA, MORTALIDADE, ESTUDOS LONGITUDINAIS, FATORES SOCIOECONÔMICOS, COMORBIDADE, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANZANI, Otavio T et al. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010-15: a population-based, longitudinal study. Lancet infectious diseases, v. 20, n. 1, p. 123-132, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(19)30518-3. Acesso em: 02 nov. 2025.
APA
Ranzani, O. T., Rodrigues, L. C., Bombarda, S., Minto, C. M., Waldman, E. A., & Carvalho, C. R. de. (2020). Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010-15: a population-based, longitudinal study. Lancet infectious diseases, 20( 1), 123-132. doi:10.1016/S1473-3099(19)30518-3
NLM
Ranzani OT, Rodrigues LC, Bombarda S, Minto CM, Waldman EA, Carvalho CR de. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010-15: a population-based, longitudinal study [Internet]. Lancet infectious diseases. 2020 ; 20( 1): 123-132.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30518-3
Vancouver
Ranzani OT, Rodrigues LC, Bombarda S, Minto CM, Waldman EA, Carvalho CR de. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010-15: a population-based, longitudinal study [Internet]. Lancet infectious diseases. 2020 ; 20( 1): 123-132.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30518-3
Artigo de periodico
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial (2020)
Kallás, Esper Georges ; Precioso, Alexander Roberto; Palacios, Ricardo; Thome, Beatriz; Braga, Patricia Emilia; Vanni, Tazio; Campos, Lucia M. A; Ferrari, Lilian; Mondini, Gabriella; Kalil Filho, Jorge Elias
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: ANTICORPOS, IMUNOGENICIDADE DA VACINA, MÉTODO DUPLO-CEGO, VÍRUS DA DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLÁS, Esper Georges et al. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, v. 20, n. 7, p. 839-850, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(20)30023-2. Acesso em: 02 nov. 2025.
APA
Kallás, E. G., Precioso, A. R., Palacios, R., Thome, B., Braga, P. E., Vanni, T., et al. (2020). Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, 20( 7), 839-850. doi:10.1016/S1473-3099(20)30023-2
NLM
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(20)30023-2
Vancouver
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(20)30023-2
Artigo de periodico
Predictors of mortality in patients with yellow fever: an observational cohort study (2019)
Kallás, Esper Georges; Zanella, Luiz Gonzaga F. A. B. D'Elia; V, Carlos Henrique Moreira; Buccheri, Renata; Diniz, Gabriela B. F; Castineiras, Anna Carla P; Costa, Priscilla R; Dias, Juliana Z. C; Sabino, Ester Cerdeira ; Silva, Vivian Helena Iida Avelino da
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: ESTUDOS DE COORTES, FEBRE AMARELA, HOSPITAIS, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLÁS, Esper Georges et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet infectious diseases, v. 19, n. 7, p. 750-758, 2019Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(19)30125-2. Acesso em: 02 nov. 2025.
APA
Kallás, E. G., Zanella, L. G. F. A. B. D. 'E., V, C. H. M., Buccheri, R., Diniz, G. B. F., Castineiras, A. C. P., et al. (2019). Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet infectious diseases, 19( 7), 750-758. doi:10.1016/S1473-3099(19)30125-2
NLM
Kallás EG, Zanella LGFABD'E, V CHM, Buccheri R, Diniz GBF, Castineiras ACP, Costa PR, Dias JZC, Sabino EC, Silva VHIA da. Predictors of mortality in patients with yellow fever: an observational cohort study [Internet]. Lancet infectious diseases. 2019 ; 19( 7): 750-758.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30125-2
Vancouver
Kallás EG, Zanella LGFABD'E, V CHM, Buccheri R, Diniz GBF, Castineiras ACP, Costa PR, Dias JZC, Sabino EC, Silva VHIA da. Predictors of mortality in patients with yellow fever: an observational cohort study [Internet]. Lancet infectious diseases. 2019 ; 19( 7): 750-758.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30125-2
Artigo de periodico
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine (2019)
Wilder-smith, Annelies; Novaes, Hillegonde Maria
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: IMUNIZAÇÃO, VACINAS VIRAIS, DENGUE, POLÍTICA DE SAÚDE, ESTRATÉGIAS MUNDIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDER-SMITH, Annelies e NOVAES, Hillegonde Maria. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. Lancet infectious diseases, v. 19, n. 1, p. E31-E38, 2019Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30494-8. Acesso em: 02 nov. 2025.
APA
Wilder-smith, A., & Novaes, H. M. (2019). Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. Lancet infectious diseases, 19( 1), E31-E38. doi:10.1016/S1473-3099(18)30494-8
NLM
Wilder-smith A, Novaes HM. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine [Internet]. Lancet infectious diseases. 2019 ; 19( 1): E31-E38.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30494-8
Vancouver
Wilder-smith A, Novaes HM. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine [Internet]. Lancet infectious diseases. 2019 ; 19( 1): E31-E38.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30494-8
Artigo de periodico-carta/editorial
Modelling the importation risk of measles during the Hajj [Carta] (2019)
Massad, Eduardo ; Wilder-smith, Annika B; Wilder-smith, Annelies; Memish, Ziad A
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: SARAMPO, DOENÇAS TRANSMISSÍVEIS, MODELAGEM DE EPIDEMIA, PREVENÇÃO DE DOENÇAS, PEREGRINOS, FESTAS RELIGIOSAS, ISLAMISMO, ORIENTE MÉDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo et al. Modelling the importation risk of measles during the Hajj [Carta]. Lancet infectious diseases. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(19)30356-1. Acesso em: 02 nov. 2025. , 2019
APA
Massad, E., Wilder-smith, A. B., Wilder-smith, A., & Memish, Z. A. (2019). Modelling the importation risk of measles during the Hajj [Carta]. Lancet infectious diseases. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S1473-3099(19)30356-1
NLM
Massad E, Wilder-smith AB, Wilder-smith A, Memish ZA. Modelling the importation risk of measles during the Hajj [Carta] [Internet]. Lancet infectious diseases. 2019 ; 19( 8): 806-806.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30356-1
Vancouver
Massad E, Wilder-smith AB, Wilder-smith A, Memish ZA. Modelling the importation risk of measles during the Hajj [Carta] [Internet]. Lancet infectious diseases. 2019 ; 19( 8): 806-806.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(19)30356-1
Artigo de periodico
Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response (2019)
Koopmans, Marion; Lamballerie, Xavier de; Jaenisch, Thomas; Rosenberger, Kerstin D; Morales, Ivonne; Marques, Ernesto T. A; Viana, Isabelle F. T; Brasil, Patricia; Rabello, Renata; Silva, Vivian Helena Iida Avelino da; Segurado, Aluísio Augusto Cotrim
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: ZIKA VÍRUS, SURTOS DE DOENÇAS, INCIDÊNCIA, FATORES DE RISCO, GRAVIDEZ, FINANCIAMENTO DA ASSISTÊNCIA À SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOOPMANS, Marion et al. Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response. Lancet infectious diseases, v. 19, n. 2, p. E59-E62, 2019Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30497-3. Acesso em: 02 nov. 2025.
APA
Koopmans, M., Lamballerie, X. de, Jaenisch, T., Rosenberger, K. D., Morales, I., Marques, E. T. A., et al. (2019). Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response. Lancet infectious diseases, 19( 2), E59-E62. doi:10.1016/S1473-3099(18)30497-3
NLM
Koopmans M, Lamballerie X de, Jaenisch T, Rosenberger KD, Morales I, Marques ETA, Viana IFT, Brasil P, Rabello R, Silva VHIA da, Segurado AAC. Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response [Internet]. Lancet infectious diseases. 2019 ; 19( 2): E59-E62.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30497-3
Vancouver
Koopmans M, Lamballerie X de, Jaenisch T, Rosenberger KD, Morales I, Marques ETA, Viana IFT, Brasil P, Rabello R, Silva VHIA da, Segurado AAC. Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response [Internet]. Lancet infectious diseases. 2019 ; 19( 2): E59-E62.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30497-3
Artigo de periodico
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015' (2018)
Murray, Christopher J. L.; Bensenor, Isabela
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: TUBERCULOSE PULMONAR, HIV, INFECÇÕES OPORTUNISTAS, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURRAY, Christopher J. L. e BENSENOR, Isabela. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015'. Lancet infectious diseases, v. 18, n. 3, p. 261-284, 2018Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(17)30703-X. Acesso em: 02 nov. 2025.
APA
Murray, C. J. L., & Bensenor, I. (2018). The global burden of tuberculosis: results from the Global Burden of Disease Study 2015'. Lancet infectious diseases, 18( 3), 261-284. doi:10.1016/S1473-3099(17)30703-X
NLM
Murray CJL, Bensenor I. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015' [Internet]. Lancet infectious diseases. 2018 ; 18( 3): 261-284.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(17)30703-X
Vancouver
Murray CJL, Bensenor I. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015' [Internet]. Lancet infectious diseases. 2018 ; 18( 3): 261-284.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(17)30703-X
Artigo de periodico
Development of vaccines against Zika virus (2018)
Poland, Gregory A.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Palacios, Ricardo; Ho, Paulo Lee; Kalil Filho, Jorge Elias
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: DENGUE, ZIKA VÍRUS, FEBRE AMARELA SILVESTRE, TRANSMISSÃO DE DOENÇAS, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLAND, Gregory A. et al. Development of vaccines against Zika virus. Lancet infectious diseases, v. 18, n. 7, p. E211-E219, 2018Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30063-X. Acesso em: 02 nov. 2025.
APA
Poland, G. A., Kennedy, R. B., Ovsyannikova, I. G., Palacios, R., Ho, P. L., & Kalil Filho, J. E. (2018). Development of vaccines against Zika virus. Lancet infectious diseases, 18( 7), E211-E219. doi:10.1016/S1473-3099(18)30063-X
NLM
Poland GA, Kennedy RB, Ovsyannikova IG, Palacios R, Ho PL, Kalil Filho JE. Development of vaccines against Zika virus [Internet]. Lancet infectious diseases. 2018 ; 18( 7): E211-E219.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30063-X
Vancouver
Poland GA, Kennedy RB, Ovsyannikova IG, Palacios R, Ho PL, Kalil Filho JE. Development of vaccines against Zika virus [Internet]. Lancet infectious diseases. 2018 ; 18( 7): E211-E219.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30063-X
Artigo de periodico
Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study (2018)
Kyu, Hmwe Hmwe; Benseñor, Isabela Judith Martins
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: TUBERCULOSE, EPIDEMIOLOGIA ANALÍTICA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KYU, Hmwe Hmwe e BENSEÑOR, Isabela Judith Martins. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet infectious diseases, v. 18, n. 12, p. 1329-1349, 2018Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30625-X. Acesso em: 02 nov. 2025.
APA
Kyu, H. H., & Benseñor, I. J. M. (2018). Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet infectious diseases, 18( 12), 1329-1349. doi:10.1016/S1473-3099(18)30625-X
NLM
Kyu HH, Benseñor IJM. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study [Internet]. Lancet infectious diseases. 2018 ; 18( 12): 1329-1349.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30625-X
Vancouver
Kyu HH, Benseñor IJM. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study [Internet]. Lancet infectious diseases. 2018 ; 18( 12): 1329-1349.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30625-X
Artigo de periodico
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 (2018)
Troeger, Christopher; Blacker, Brigette F; Khalil, Ibrahim A; Rao, Puja C; Cao, Shujin; Zimsen, Stephanie R. M; Albertson, Sam; Stanaway, Jeffery D; Deshpande, Aniruddha; Brown, Alexandria; Benseñor, Isabela M
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: DIARREIA, MORBIDADE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROEGER, Christopher et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet infectious diseases, v. 18, n. 11, p. 1211-1228, 2018Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30362-1. Acesso em: 02 nov. 2025.
APA
Troeger, C., Blacker, B. F., Khalil, I. A., Rao, P. C., Cao, S., Zimsen, S. R. M., et al. (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet infectious diseases, 18( 11), 1211-1228. doi:10.1016/S1473-3099(18)30362-1
NLM
Troeger C, Blacker BF, Khalil IA, Rao PC, Cao S, Zimsen SRM, Albertson S, Stanaway JD, Deshpande A, Brown A, Benseñor IM. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet infectious diseases. 2018 ; 18( 11): 1211-1228.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30362-1
Vancouver
Troeger C, Blacker BF, Khalil IA, Rao PC, Cao S, Zimsen SRM, Albertson S, Stanaway JD, Deshpande A, Brown A, Benseñor IM. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet infectious diseases. 2018 ; 18( 11): 1211-1228.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(18)30362-1
Artigo de periodico
Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak (2018)
Musso, Didier; Sabino, Ester Cerdeira
Fonte: Lancet infectious diseases. Unidade: FM
Assuntos: ZIKA VÍRUS, AEDES, COMPLICAÇÕES INFECCIOSAS NA GRAVIDEZ, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUSSO, Didier e SABINO, Ester Cerdeira. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak. Lancet infectious diseases, v. 18, n. 5, p. E172-E182, 2018Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(17)30446-2. Acesso em: 02 nov. 2025.
APA
Musso, D., & Sabino, E. C. (2018). Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak. Lancet infectious diseases, 18( 5), E172-E182. doi:10.1016/S1473-3099(17)30446-2
NLM
Musso D, Sabino EC. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak [Internet]. Lancet infectious diseases. 2018 ; 18( 5): E172-E182.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(17)30446-2
Vancouver
Musso D, Sabino EC. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak [Internet]. Lancet infectious diseases. 2018 ; 18( 5): E172-E182.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(17)30446-2

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Agência de fomento